BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

  January 5, 2026

   · 

  5 min read
• Press Releases

  TME Pharma provides update on its activities

  January 5, 2026

   · 

  7 min read
• Press Releases

  Earendil Labs Announces Strategic Collaboration with Sanofi to Discover Bispecific Antibodies for Autoimmune Diseases

  January 5, 2026

   · 

  2 min read
• Press Releases

  Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes

  January 5, 2026

   · 

  7 min read
• Press Releases

  Idorsia’s JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension

  January 5, 2026

   · 

  8 min read
• Press Releases

  BioInvent Reports Promising Data from Ongoing Phase 2a study for BI-1808 with KEYTRUDA(R) (pembrolizumab) in Recurrent Ovarian Cancer

  January 5, 2026

   · 

  7 min read
• Press Releases

  argenx Announces Leadership Transition Marking Next Evolution of Growth

  January 5, 2026

   · 

  5 min read
• Press Releases

  Invisible Danger: Lung Association Urges Home Testing for Cancer-Causing Radon Gas

  January 5, 2026

   · 

  4 min read
• Press Releases

  Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

  January 5, 2026

   · 

  17 min read
• Press Releases

  Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference

  January 5, 2026

   · 

  10 min read